Hydrokortison Evolan (Hydrocortisone)

Hydrocortisone binds to intracellular glucocorticoid receptors, forming a complex that enters the cell nucleus and alters gene transcription. This down‑regulates pro‑inflammatory cytokines, chemokines and enzymes, leading to decreased vascular permeability, reduced leukocyte migration and overall suppression of the inflammatory response in the skin.

The prescribed dose of Hydrokortison Evolan is determined by the treating clinician based on the severity and location of the skin condition. Typically, a thin layer is applied to the affected area once or twice daily, but exact frequency, amount and treatment duration should follow the prescriber’s instructions.

Safety data for topical hydrocortisone in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare professional.

To request Hydrokortison Evolan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the enquiry, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Hydrokortison Evolan contains hydrocortisone, a low‑ to medium‑potency corticosteroid. Compared with higher‑potency agents such as clobetasol or betamethasone, it carries a lower risk of skin atrophy and systemic absorption, making it suitable for mild to moderate inflammation and for use on larger body surface areas or on sensitive skin.

Store Hydrokortison Evolan at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability.

Hydrokortison Evolan is applied topically. Clean and gently dry the affected skin, then spread a thin layer of the cream or ointment over the lesion. Avoid contact with eyes, mouth, nostrils and broken skin unless directed by a healthcare professional. Wash hands after application.

Serious adverse reactions, although uncommon, include severe allergic responses such as anaphylaxis, marked skin thinning (atrophy) with prolonged use, and secondary bacterial, fungal or viral infections at the application site. Any signs of worsening skin condition, unusual swelling, or systemic symptoms should prompt immediate medical evaluation.

Hydrokortison Evolan should be avoided in individuals with known hypersensitivity to hydrocortisone or any excipients in the formulation. It is also contraindicated on skin infected with viral (e.g., herpes simplex), bacterial or fungal pathogens unless specifically prescribed, and should not be used on extensive broken skin without medical supervision.